ASKA Pharmaceutical Co., Ltd. Stock Japan Exchange
Equities
4514
JP3541200006
Pharmaceuticals
Sales 2024 * | 63.28B 407M | Sales 2025 * | 64.65B 416M | Capitalization | 63.17B 406M |
---|---|---|---|---|---|
Net income 2024 * | 6.47B 41.6M | Net income 2025 * | 4.89B 31.49M | EV / Sales 2024 * | 0.74 x |
Net cash position 2024 * | 16.35B 105M | Net cash position 2025 * | 20.83B 134M | EV / Sales 2025 * | 0.65 x |
P/E ratio 2024 * |
9.76
x | P/E ratio 2025 * |
12.9
x | Employees | 747 |
Yield 2024 * |
1.79% | Yield 2025 * |
2.15% | Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
President | 72 | 21-03-31 | |
Kiyohiko Tamura
ADM | Chief Administrative Officer | - | - |
Kunihiro Gunji
CMP | Compliance Officer | - | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 72 | 21-03-31 | |
Atsushi Maruo
BRD | Director/Board Member | 65 | 21-03-31 |
Director/Board Member | 75 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+33.43% | 700B | |
+27.63% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.18% | 236B | |
+6.62% | 202B | |
-9.24% | 197B | |
+4.26% | 161B |